Welcome to Current Partnering – life science intelligence for deal makers

We are the publisher of CP Reports – life science deal term reports. We also produce Current Agreements – the leading comprehensive partnering, M&A, financing and company database.

In addition, we offer CP Insight – an interactive platform for an advanced level of deal making intelligence, and CP Knowledge Centre – our 3-in-1 life science intelligence package – ideal for users who need comprehensive access to all that Current Partnering has to offer.

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Genmab and Seattle Genetics become biotech partners for developing ADC

September 11, 2014 : big biotech, biotech deals, biotech partnering

Seattle Genetics becomes a biotech partner of Genmab for developing antibody-drug conjugate (ADC). more »

Trialbee joins hands with big pharma AstraZeneca

September 11, 2014 : big pharma, pharma partnering

E-health company Trialbee signs professional service agreement with big pharma. AstraZeneca for e-recruitment. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

Google acquires Lift Labs, a medical device company

September 12, 2014 : acquisition, M&A, medical device

Google has acquired San Francisco-based Lift Labs for an undisclosed amount.

more »

Mylan announces the acquisition of Arixtra from Aspen

September 11, 2014 : acquisition, asset purchase, big pharma, Mylan

Mylan announces the acquistion of the U.S. commercialization, marketing and intellectual property rights of Arixtra. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Cornindus raises $26.6 million in private placement financing

September 15, 2014 : financing, financings

Cornindus  Vascular Robotic  raises $26.6 million in private placement financing. more »

Virobay files for $50 million in IPO financing

September 12, 2014 : financing, financings

Virobay has filed a S-1 form with the Securities and Exchange Commission for $50 million towards an initial public offering. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Akorn to bid for an acquisition of UCB’s subsidiary

September 15, 2014 : acquisition, dealtalk, M&A

Akorn targets UCB’s subsidiary for acquisition for tax inversion.  more »

Orphan diseases partnering: A lucrative step for drug makers

September 2, 2014 : M&A, orphan diseases, partnering

By Shamini Thiagarajan

Increased collaborations, big pharma involvements, venture capital investments, and medical/technological breakthroughs are together changing the landscape of research and development in orphan diseases. more »

 More dealtalk

Featured reports

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

Vaccine Partnering Terms and Agreements

Publication date: July 2014

Distribution Partnering Terms and Agreements

Publication date: July 2014

Diagnostics Partnering Terms and Agreements

Publication date: July 2014

Pharma and Biotech M&A Trends 2009-2014

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
bannerpng
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
bpa14banner300x150jpg
currentpartneringpharma-bio300x150gif